The ladder is genuinely well published
Each product card carries a plan selector with two lanes. The three-month lane shows a per-month figure and the total paid up front. The monthly lane shows the ongoing per-month figure and, beneath it, a lower first month.
That is four numbers per drug, all visible before an intake, and it is the disclosure most sellers here skip. Fourteen of the ninety-five sellers here carry a recorded introductory rate; the ones that print the ongoing rate beside it are a smaller group again.
The card also states the terms in the seller's own words: same price at any dose, no hidden fees, no commitments, cancel anytime. And the site states separately, under its own heading, that there are no membership fees. Forty-one of the ninety-five sellers here charge no membership.
Everything is priced against something struck through
Both products carry a regular price with a line through it and a sale price beneath. Both carry a claim about how much less the plan costs than something. And a banner across every page announces summer deals and a big saving.
It was the sixth of September when we read it. A seasonal sale banner that has outlived its season is a small thing, but it is the same small thing as a countdown timer that never runs out: it tells you the discount is the price and the struck figure is a device.
Read together with the first-month rate, that is three separate reasons the advertised number is not the number you will be paying in month two. Our record stores the ongoing rate as well as the plan rate for exactly that reason, and this row does not score for price stability.
A page about pharmacies that names none
The footer of every page links to something headed pharmacy providers. Open it and the content is: a sentence defining what a pharmacy provider is, a street address in Florida, a partners email address, a phone number and a contact form.
No pharmacy is named on it. The product pages say the medication is compounded by accredited, high-standard pharmacies, which is a category with an adjective attached. Sixty-nine of the ninety-five sellers here name no compounding pharmacy at all.
A page created to answer the pharmacy question and then not answering it is worse than silence, because it looks like a disclosure in a site map and in a footer. If you need to know who compounds your medication, ask before you order; the page that appears to promise it does not deliver it.
The FDA letter, and what changed
The agency reviewed this site in March 2026 and wrote in June. The letter names the domain and a federal establishment identifier, and quotes the site's own words back at it — a claim that the compounded product contains the same active ingredient as two named brand drugs. The agency's position is that such claims represent the products as FDA-approved or evaluated for safety and effectiveness when they are not.
Fourteen of the ninety-five sellers here carry a recorded FDA warning letter. It is a disclosure and not a finding of guilt, and this comparison does not score a company down for one. The number, the date and a link sit on this row.
One thing is worth reporting precisely because it is favourable. We searched the visible text of both product pages on 6 September 2026 for the sentence the letter quotes. It returns zero occurrences on both. That is an observation about two pages on one date — not a statement that the matter is resolved, which is not something we can read anywhere.
Two companies, no clinician, no state list
The Terms distinguish the platform company from the medical practice and name both, which is a cleaner disclosure than most of this field manages, and the Notice of Privacy Practices names the platform company again as the entity holding the records.
No individual clinician is named anywhere on the pages we read. Fifty-one of the ninety-five sellers here name nobody who prescribes.
On coverage the Terms are explicit that the service may not reach you: they state that the company and the practices operate subject to state and federal regulations and that the services may not be available in your state. No list follows. Fifty-eight of the ninety-five sellers here publish no service area at all — but stating the limitation and then not resolving it is a particular kind of unhelpful.
NativeMed's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $149/moThe three-month starter plan with the prepaid total printed: "3 Month STARTER / $328 less / $149/mo | $449 / paid upfront", against a struck regular price of $299.00. The card adds "✓ SAME PRICE ANY DOSE. ✓ NO HIDDEN FEES. ✓ NO COMMITMENTS. ✓ CANCEL ANYTIME." | September 2026source |
| Semaglutide (compounded) | $179/moThe ongoing month-to-month rate on the same card: "monthly / $179 / per month / first month $159". This is the figure that survives after the introductory month. | September 2026source |
| Tirzepatide (compounded) | $183/moThe three-month starter plan with the total printed: "3 Month STARTER / $508 less / $183/mo | $549 / paid upfront", against a struck regular price of $399.00. | September 2026source |
| Tirzepatide (compounded) | $259/moThe ongoing month-to-month rate: "monthly / $259 / per month / first month $199". | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 95 providers reviewed here are paid partners today; the other 91 are not. See how this works.
See NativeMed's current price →Good fit if
- Readers who want the first-month rate and the ongoing rate printed on the same card rather than discovering the second one later.
- Buyers who want the prepaid total shown beside the per-month figure on the multi-month lane.
- People who want a stated absence of membership fees and commitments, under its own heading.
- Anyone who wants the platform company and the medical practice named separately.
Look elsewhere if
- Anyone comparing on the advertised number. It is discounted three ways at once — a struck regular price, a seasonal banner and a first-month rate.
- Readers who need the compounding pharmacy named. The page that appears to promise it names none.
- Buyers for whom an FDA warning letter about product claims is a filter.
- Anyone who needs their state confirmed. The Terms say the service may not be available where you are and never say where it is.
- Readers who want an individual prescribing clinician named.
How this review was verified
- Re-read both product pages, the Terms of Service, the Notice of Privacy Practices and the page headed pharmacy providers on 6 September 2026 rather than carrying any figure across from the research file that nominated this seller.
- Read the pharmacy page in full and recorded what is on it — a definition, an address, an email, a phone number and a form — rather than reporting the page's existence as a disclosure.
- Recorded four figures per drug (plan rate, prepaid total, first month, ongoing rate) rather than storing one headline, and put the first-month rates in the introductory-offer field so no tool treats them as an ongoing price.
- Read the FDA warning letter, took the sentence it quotes, and searched for it in the extracted visible text of both product pages. Zero occurrences on both, reported as an observation on one date.
- Fetched the warning letter URL and confirmed it returns a real page, with a nonsense warning-letter path on the same host in the same run returning 404.
- Printed the status, byte size and effective URL of every fetch and compared the effective path to the requested one. This host's nonsense-path control returned 404 carrying more than a hundred and twenty thousand bytes, which is why nothing here was judged by size.
- Extracted every figure from a Python html.parser pass over text nodes only, with residual markup asserted absent.
- Screened both named entities and the brand against FDA's live warning-letter record with a positive control and a nonsense-string negative control in the same run. Untitled letters are published separately and were not searched.